µ¼Ê¦ÐÕÃû£ºÂ½Ð¡ÔÆ
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º51
ËùÊôԺУ£ºôßÄÏ´óѧ
ËùÊôԺϵ£ºÒ©Ñ§Ôº
Ö°³Æ£ºÑо¿Ô±
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º 1.ÐÂÐÍ¿¹·Î°©³ÉÒ©ÐÔÏȵ¼»¯ºÏÎïµÄÑо¿2.¿Ë·þÁÙ´²ÄÍÒ©µÄÐÂÐÍ¿¹½áºËÒ©ÎïÑо¿3.ÆäËûÐÂÐͼ¤Ã¸Àà... [Õ¹¿ª]
Ñо¿ÁìÓò£º 1.ÐÂÐÍ¿¹·Î°©³ÉÒ©ÐÔÏȵ¼»¯ºÏÎïµÄÑо¿2.¿Ë·þÁÙ´²ÄÍÒ©µÄÐÂÐÍ¿¹½áºËÒ©ÎïÑо¿3.ÆäËûÐÂÐͼ¤Ã¸ÀàÒÖÖÆ¼ÁµÄÉè¼ÆÑо¿ [ÊÕÆð]
ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºluxy2016@jnu.edu.cn
¸öÈ˼òÊö :
Â½Ð¡ÔÆ£¬Å®£¬²©Ê¿£¬Ñо¿Ô±£¬¹ã¶«Ê¡½Ü³öÇàÄê»ù½ð»ñµÃÕߣ¬863ÇàÄê¿ÆÑ§¼ÒÏîÄ¿»ñµÃÕߣ¬¹ã¶«Ê¡ÌØÖ§¼Æ»®ÇàÄê°Î¼âÈ˲ţ¬¹ãÖÝÊÐÖé½ÐÂÐÇ¡£2005Äê6Ô±ÏÒµÓÚÖйúÒ©¿Æ´óÑ§ÖÆÒ©¹¤³ÌöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñѧʿѧλ£»2010Äê6Ô±ÏÒµÓÚÖйúÒ©¿Æ´óѧҩÎﻯѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñÀíѧ²©Ê¿Ñ§Î»£»2010Äê7ÔÂ-2016Äê2ÔÂÔÚÖйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿Ôº´ÓÊ¿ÆÑй¤×÷£¬2012Äê1Ô±»Æ¸Îª¸±Ñо¿Ô±£»2016Äê3Ô¼ÓÈëôßÄÏ´óѧҩѧԺ£¬´ÓʽÌѧ¿ÆÑй¤×÷¡£ ´ÓÊ´´ÐÂÒ©ÎïÏȵ¼»¯ºÏÎïµÄ·¢ÏÖÑо¿¡£Ö÷ÒªÃé×¼·Î²¿¼²²¡£¨·Î°©ºÍ½áºË²¡µÈ£©ÁÙ´²ÄÍÒ©ÎÊÌ⣬Éè¼ÆºÍºÏ³É¾ßÓÐÖØÒªÉúÎïѧ¹¦ÄܺÍÁ¼ºÃ³ÉÒ©ÐÔµÄÏȵ¼»¯ºÏÎΪ´´ÐÂÒ©Î↑·¢µì¶¨»ù´¡¡£ÏÖÖ÷³Ö863ÇàÄê¿ÆÑ§¼ÒÏîÄ¿£¬¹ã¶«Ê¡½Ü³öÇàÄêÏîÄ¿£¬¹ã¶«Ê¡ÌØÖ§¼Æ»®ÇàÄê°Î¼âÈ˲ź͹ãÖÝÊÐÖé½ÐÂÐǵÈÑо¿¿ÎÌâ¡£ÒÑÔÚAngew. Chem. Int. Ed.ºÍJ. Med. Chem µÈÖØÒªöλÔÓéÀֵǼÈë¿ÚÏÂÔØÆÚ¿¯·¢±íµÚÒ»×÷Õß»òͨѶ×÷ÕßSCIÂÛÎÄ30ÓàÆª£¬ÉêÇë·¢Ã÷רÀû20ÓàÏÊÚȨ10ÏPCT 4Ï£¬²¿·ÖרÀûÒÑʵÏÖ×ªÒÆ×ª»¯¡£Ôø»ñÖйúҩѧ»á-ʩάÑÅÒ©Îﻯѧ½±£¬ÖпÆÔºÂ¬¼ÎÎýÇàÈ˲ޱµÈ½±Ïî¡£
¿ÆÑй¤×÷ :
1. Qiujue Xun*, Zhang Zhang*, Jinfeng Luo, Lingjiang Tong, Minghao Huang, zhen Wang, Jian Zou, Yong Xu, Hua Xie, Zheng-Chao Tu, Xiaoyun Lu*, Ke Ding*.Design, Synthesis and Structure-Activity Relationship Study of 2-Oxo-3, 4-dihydropyrimido[4, 5-d] Pyrimidines as New Colony Stimulating Factor-1 Receptor (CSF1R) Kinase Inhibitors. J. Med. Chem. 2018, doi: 10.1021/acs.jmedchem.7b016122. Xiaoyun Lu*, Lei Yu, Zhang Zhang, Xiaomei Ren, Jeff B Smaill, Ke Ding*. Targeting EGFRL858R/T790M and EGFRL858R/T790M/C797S resistance mutations in NSCLC: Current developments in medicinal chemistry. Med. Res. Rev. 2018, doi: 10.1002/med.21488.3. Yu Chang#, Xiaoyun Lu#, Marthiandam Asokan Shibu#, YiBo Dai#, Jinfeng Luo, Yan Zhang, Yingjun Li, Peng Zhao, Zhang Zhang, Yong Xu, Zheng Chao Tu, Qingwen Zhang*, Caihong Yun*, Chih.-Yang Huang*, and Ke Ding*. Structure-Based Design of N-(3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl) Benzenesulfonamides as Selective Leucine- Zipper and Sterile-¦Á Motif Kinase (ZAK) Inhibitors. J. Med. Chem. 2017, 60(13):5927-5932.
ôßÄÏ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Â½Ð¡ÔÆ
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/Ò©Îï ÁÙ´² È˲е¼Ê¦ ±ÏÒµ
ôßÄÏ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-³ÂÏþ²¨
µ¼Ê¦ÐÕÃû£º³ÂÏþ²¨ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºôßÄÏ´óѧËùÊôԺϵ£ºÀí¹¤Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1.µÚÒ»ÐÔÔÀí¼ÆËã·½·¨¼°ÆäÔÚ¸ßÐÔÄܼ¯ÈºÉϵÄʵÏÖ¡£2.ÄÉÃ׳߶ȴ߻¯¼ÁµÄ·´Ó¦»úÀíÑо¿¡£3.ï®Àë...[Õ¹¿ª]Ñо¿ÁìÓò£º1.µÚÒ»ÐÔÔÀí¼ÆËã·½·¨¼°ÆäÔÚ¸ßÐÔÄܼ¯ÈºÉϵÄʵÏÖ¡£2.ÄÉÃ׳߶ȴ߻¯¼Á ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ôßÄÏ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÑîÃÈ
µ¼Ê¦ÐÕÃû£ºÑîÃÈÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºôßÄÏ´óѧËùÊôԺϵ£º·¨Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÐÌ·¨Ñ§¡¢±È½ÏÐÌ·¨Ñ§¡¢Íâ¹úÐÌ·¨Ñ§¡¢¾¼ÃÐÌ·¨Ñ§Ñо¿ÁìÓò£ºÐÌ·¨Ñ§¡¢±È½ÏÐÌ·¨Ñ§¡¢Íâ¹úÐÌ·¨Ñ§¡¢¾¼ÃÐÌ·¨Ñ§[ÊÕÆð]¿ÆÑй¤×÷:³Ðµ£¿ÎÌ⣺1¡¢Ö÷³Ö¹ã¶«Ê¡Éç¿Æ2012Äê¡°Ê®¶þÎå¡°¹æ»®ÇàÄêÏîÄ¿¡¶·çÏÕÉç»á¡± ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÌÆ¹¦Àû
µ¼Ê¦ÐÕÃû£ºÌƹ¦ÀûÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÌìȻҩÎﻯѧͨѶ·½Ê½:µç×ÓÓʼþ£ºgltang@sioc.ac.cn ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ËκéÌÎ
µ¼Ê¦ÐÕÃû£ºËκéÌÎÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºÖ÷ÈÎҩʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©¼Áѧ¡¢ÁÙ´²Ò©Ñ§¡¢Ò©Ñ§£¨ÁÙ´²Ò©Ñ§·½Ïò£©¡¢Ò©Ñ§£¨Ò©¼Áѧ·½Ïò£©Í¨Ñ¶·½Ê½:µç×ÓÓʼþ£ºsohoto@vip.163.comͨѶµØÖ·£º¸£½¨Ê¡¸£ÖÝÊйÄÂ¥ÇøÎ÷¶þ»·±±Â·156ºÅ¸öÈ˼òÊö:ËκéÌΣ¬ÄУ¬²©Ê¿ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-»ÆÄËÕý
µ¼Ê¦ÐÕÃû£º»ÆÄËÕýÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£º²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Îﻯѧ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÁÉÄþʯÓÍ»¯¹¤´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Âí¿¥
µ¼Ê¦ÐÕÃû£ºÂí¿¥ÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÁÉÄþʯÓÍ»¯¹¤´óѧËùÊôԺϵ£ºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÇå½àȼÁÏÉú²ú¼¼Êõ£»ÖØÖÊÓ͸ÄÐÔ´ß»¯¼ÁÑо¿¡£Ñо¿ÁìÓò£ºÇå½àȼÁÏÉú²ú¼¼Êõ£»ÖØÖÊÓ͸ÄÐÔ´ß»¯¼ÁÑо¿¡£[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºjunma1212@126.com¸öÈ˼òÊö:ÄУ¬1967Äê12 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Áαù
µ¼Ê¦ÐÕÃû£ºÁαùÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£º¹«¹²¹ÜÀíѧԺְ³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¸öÈ˼òÊö:Áαù£¬ÖØÇì´óѧ¾¼ÃÓ빤É̹ÜÀíѧԺ¸±Ôº³¤£¬¸±½ÌÊÚ£¬²©Ê¿£¬Ë¶Ê¿Éúµ¼Ê¦¡£1990Äê±ÏÒµÓÚÎ÷ÄÏʦ·¶´óѧÐÄÀíѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ»ñѧʿѧ룬1996Äê»ñµÃÎ÷ÄÏʦ·¶´óѧÐÄÀíѧ˶ʿѧ룬2010Äê»ñµÃÖØÇì´óѧ¼¼Êõ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Ò¶Ïþ®d
µ¼Ê¦ÐÕÃû£ºÒ¶Ïþ®dÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£º¾¼ÃÓ빤É̹ÜÀíѧԺְ³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1¡¢¹«¹²ÏîÄ¿¹«Ë½ºÏ×÷ÈÚ×Ê·çÏÕ¹ÜÀí£¨PPP/BOT£©£»2¡¢¹¤³Ì²ÆÎñ£¨²ÆÎñÔ¤¾¯·½°¸¡¢¹¤³Ì³É±¾¿Ø...[Õ¹¿ª]Ñо¿ÁìÓò£º1¡¢¹«¹²ÏîÄ¿¹«Ë½ºÏ×÷ÈÚ×Ê·çÏÕ¹ÜÀí£¨PPP/BOT£©£»2¡¢¹¤³Ì²ÆÎñ£¨²Æ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÍõêÅ
µ¼Ê¦ÐÕÃû£ºÍõêÅÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£º¾¼ÃÓ빤É̹ÜÀíѧԺְ³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÊý¾ÝÍÚ¾òÄ£ÐÍËã·¨¼°ÆäÔÚÉÌÎñÖÇÄÜÖеÄÓ¦Óá£Ñо¿ÁìÓò£ºÊý¾ÝÍÚ¾òÄ£ÐÍËã·¨¼°ÆäÔÚÉÌÎñÖÇÄÜÖеÄÓ¦Óá£[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºyuwang@cqu.edu.cn¿ÆÑй¤×÷:Ñо¿ÏîÄ¿£º×÷ΪÏî ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÊæºìÓî
µ¼Ê¦ÐÕÃû£ºÊæºìÓîÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1£®³µÁ¾ÏµÍ³¶¯Á¦Ñ§£»2£®Æû³µµç×ÓÓë¿ØÖÆ¼¼Êõ3£®³µÁ¾Õñ¶¯ÓëÔëÉù·ÖÎöÓë¿ØÖÆ4£®³µÁ¾¹ÊÕÏÕï¶ÏÓë¿Ø...[Õ¹¿ª]Ñо¿ÁìÓò£º1£®³µÁ¾ÏµÍ³¶¯Á¦Ñ§£»2£®Æû³µµç×ÓÓë¿ØÖÆ¼¼Êõ3£®³µÁ¾Õñ¶¯ÓëÔëÉù·ÖÎöÓë¿ØÖÆ4£®³µÁ¾ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-κ¾²
µ¼Ê¦ÐÕÃû£ºÎº¾²ÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£º¹«¹²¹ÜÀíѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£º²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÑо¿ÁìÓò¼¯ÖÐÔÚÌØÊâÓ뼫¶Ë»·¾³Ï³ÝÂÖ´«¶¯ÏµÍ³Éè¼ÆÀíÂÛÓë·½·¨¡¢¾«ÃÜ´«¶¯ÓëÇý¶¯¼¼Êõ¡¢³ÝÂÖ´«¶¯...[Õ¹¿ª]Ñо¿ÁìÓò£ºÖ÷ÒªÑо¿ÁìÓò¼¯ÖÐÔÚÌØÊâÓ뼫¶Ë»·¾³Ï³ÝÂÖ´«¶¯ÏµÍ³Éè¼ÆÀíÂÛÓë·½·¨¡¢¾«ÃÜ´« ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àî¶«Áá
µ¼Ê¦ÐÕÃû£ºÀî¶«ÁáÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£º¹âµç¹¤³ÌѧԺְ³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íõ¹â½¨
µ¼Ê¦ÐÕÃû£ºÍõ¹â½¨ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£º²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1.¾«ÃÜ´«¶¯¼°ÏµÍ³2.¸ßÐÔÄÜ´«¶¯»ú¹¹Éè¼Æ(ÓÈÆäÕë¶ÔÌØÊ⼫¶Ë»·¾³)3.»úÆ÷È˼¼Êõ¼°ÖÇÄÜ×°±¸Ñо¿ÁìÓò£º1.¾«ÃÜ´«¶¯¼°ÏµÍ³2.¸ßÐÔÄÜ´«¶¯»ú¹¹Éè¼Æ(ÓÈÆäÕë¶ÔÌØÊ⼫¶Ë»·¾³)3.»úÆ÷È˼¼Êõ¼°ÖÇÄÜ×°±¸[ÊÕ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-볬
µ¼Ê¦ÐÕÃû£ºÃ«³¬ÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£º½¨Éè¹ÜÀíÓë·¿µØ²úѧԺְ³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÖØÇì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÍõÐñ³õ
µ¼Ê¦ÐÕÃû£ºÍõÐñ³õÐÔ±ð£ºÈËÆøÖ¸Êý£º51ËùÊôԺУ£ºÖØÇì´óѧËùÊôԺϵ£º¹âµç¹¤³ÌѧԺְ³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖØÇì´óѧAÇø¹âµç¹¤³ÌѧԺģʽʶ±ðÑо¿ÊÒ(Ö÷½Ì1105ÊÒ)?Óʱࣺ400044Ñо¿ÁìÓò£ºÖØÇì´óѧAÇø¹âµç¹¤³ÌѧԺģʽʶ±ðÑо¿ÊÒ(Ö÷½Ì1105ÊÒ)?Óʱࣺ400044[ÊÕÆð]ͨѶ·½Ê½ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
